| 英文别名 |
N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate;Flecainide Acetate;acetic acid,N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide;Flecainide (acetate);Flecainide acetate (Tambocor®, Ecrinal®,Almarytm®, Apocard® , Flécaine);EINECS 258-997-5;Flecainide acetate salt;FLECAINIDE MONOACETATE;N-(2-Piperidylmethyl)-2,5-bis-(2,2,2-trifluoroethoxy)benzamide acetate salt;R 818;R-818;Flecainide for system suitability, European Pharmacopoeia (EP) Reference Standard;N-(2-Piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate;SCHEMBL121583;SR-01000000172;Flecainide acetate;Q27089351;SMR000058451;NC00641;SR-01000000172-5;HMS3714C12;11A-HYDROXYEPOXYPROGESTERONE;Tambocor (TN);N-(piperidin-2-ylmethyl)-2,5-bis[(2,2,2-trifluoroethyl)oxy]benzamide acetate;acetic acid;N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide;SR-01000000172-7;54143-56-5 (acetate);FLECAINIDE ACETATE [JAN];FLECAINIDE ACETATE [USP IMPURITY];F 6777;54143-56-5;AKOS015889993;FLECAINIDE ACETATE (EP MONOGRAPH);E-0735;DTXCID80626;MLS001148177;CAS-54143-56-5;FLECAINIDE ACETATE [USP MONOGRAPH];FLECAINIDE ACETATE [USAN];CCG-220735;Flecainide Acetate Tablet;Flecainide for system suitability;Benzamide, N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-,monoacetate;CHEBI:5091;Flecainide acetate [USAN:USP:JAN];D00638;SB19142;Flecainidacetat;FLECAINIDE ACETATE (MART.);FLECAINIDE ACETATE (USP MONOGRAPH);SR-01000000172-4;HMS2097C12;n-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide acetate;AS-11702;Flecainide acetate (USAN:USP:JAN);FLECAINIDE ACETATE [USP-RS];FLECAINIDE ACETATE [WHO-DD];DTXSID8020626;Opera_ID_1587;HMS3267N04;NS00076417;SR-01000000172-2;NCGC00093934-02;Flecainide acetate (JP17/USP);Flecainide acetate, European Pharmacopoeia (EP) Reference Standard;2,5-bis(2,2,2-trifluoroethoxy)-N-(2-piperidylmethyl)benzamide acetate;HMS3369M07;FLECAINIDE ACETATE (USP-RS);FT-0630667;FLECAINIDE ACETATE [EP IMPURITY];CS-1400;HMS3412D09;FLECAINIDE ACETATE [VANDF];HMS3259F11;BCP17825;NSC719273;NCGC00257762-01;HMS3676D09;FLECAINIDE ACETATE [EP MONOGRAPH];Tox21_200208;2-({[2,5-bis(2,2,2-trifluoroethoxy)benzoyl]amino}methyl)piperidinium acetate;N-(Piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate;FLECAINIDE ACETATE [ORANGE BOOK];MLS002222300;NCGC00093934-01;N-((2RS)-Piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate;FLECAINIDE ACETATE (EP IMPURITY);Flecainide acetate, United States Pharmacopeia (USP) Reference Standard;EU-0100546;Benzamide, N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-, monoacetate;CHEMBL1200822;Flecainide acetate, British Pharmacopoeia (BP) Reference Standard;N-(2-Piperidylmethyl)-2,5-bis-(2,2,2-trifluoroethoxy)benzamide acetate;HY-17429;UNII-M8U465Q1WQ;HMS1570C12;2,5-Bis-(2,2,2-trifluoroethoxy)-N-(2-piperidinylmethyl)benzamide acetate;FLEC... |
微信公众号
客服
